Abnormal levels of interferon-gamma receptors in active multiple sclerosis are normalized by IFN-beta therapy: implications for control of apoptosis.
D000328:Adult; D017209:Apoptosis; D005260:Female; D006801:Humans; D016899:Interferon-beta / Q000627:therapeutic use*; D007371:Interferon-gamma / Q000378:metabolism; D016753:Interleukin-10 / Q000378:metabolism; D008137:Longitudinal Studies; D018655:Lymphocyte Count; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D017471:Receptors, Interferon / Q000378:metabolism*; D006377:T-Lymphocytes, Helper-Inducer / Q000166:cytology; D000096743:Interferon gamma Receptor
D016899:Interferon-beta; D007371:Interferon-gamma; D016753:Interleukin-10; D017471:Receptors, Interferon; D000096743:Interferon gamma Receptor